Melissa J. Moore

Last updated
  1. 1 2 "Melissa J. Moore". National Academy of Science. Retrieved November 2, 2021.
  2. 1 2 3 Eshleman, Tina (December 15, 2020). "THE SCIENCE BEHIND THE VACCINE". College of William and Mary . Retrieved November 2, 2021.
  3. Mercuric ion reductase: mutagenesis of n- and c-terminal paired cysteines and initial crystallization studies. WorldCat. OCLC   20337577 . Retrieved November 2, 2021.
  4. Moore, Melissa J.; Sharp, Phillip A. (1992-05-15). "Site-Specific Modification of Pre-mRNA: the 2′-Hydroxyl Groups at the Splice Sites". Science. 256 (5059): 992–997. Bibcode:1992Sci...256..992M. doi:10.1126/science.1589782. PMID   1589782.
  5. Moore, Melissa J.; Sharp, Phillip A. (September 1993). "Evidence for two active sites in the spliceosome provided by stereochemistry of pre-mRNA splicing". Nature. 365 (6444): 364–368. Bibcode:1993Natur.365..364M. doi:10.1038/365364a0. ISSN   1476-4687. PMID   8397340. S2CID   4361512.
  6. Yemma, John (March 6, 1997). "Short history, high standing". The Boston Globe. Retrieved November 2, 2021 via newspapers.com.
  7. "Melissa J. Moore". Searle Scholars Program . Retrieved November 2, 2021.
  8. "Melissa J. Moore: 1994 Fellow". David and Lucile Packard Foundation . Retrieved November 2, 2021.
  9. "UMass lures top talent". The Boston Globe. September 10, 2007. Retrieved November 2, 2021 via newspapers.com.
  10. "Melissa Moore, HHMI Investigator joins BMP Faculty". University of Massachusetts Chan Medical School. April 3, 2009. Retrieved November 2, 2021.
  11. "Scientific community recognizes UMass med school researcher, mentor". Eurekalert. April 7, 2011. Retrieved November 2, 2021.
  12. "Melissa Moore wins Gates Foundation grant". University of Massachusetts Chan Medical School. April 29, 2011. Retrieved November 2, 2021.
  13. Turanov, Anton A.; Lo, Agnes; Hassler, Matthew R.; Makris, Angela; Ashar-Patel, Ami; Alterman, Julia F.; Coles, Andrew H.; Haraszti, Reka A.; Roux, Loic; Godinho, Bruno M. D. C.; Echeverria, Dimas (December 2018). "RNAi modulation of placental sFLT1 for the treatment of preeclampsia". Nature Biotechnology. 36 (12): 1164–1173. doi:10.1038/nbt.4297. ISSN   1546-1696. PMC   6526074 . PMID   30451990.
  14. Johnson, Charles Y. (November 30, 2013). "Chance meeting leads to novel preeclampsia treatment". The Boston Globe. Archived from the original on December 7, 2013. Retrieved November 2, 2021.
  15. "This mysterious $2 billion biotech is revealing the secrets behind its new drugs and vaccines". www.science.org. Retrieved 2022-02-24.
  16. "Melissa Moore to join Moderna as chief scientific officer". University of Massachusetts Chan Medical School. September 13, 2016. Retrieved November 2, 2021.
  17. "Melissa Moore elected to National Academy of Sciences". University of Massachusetts Chan Medical School. May 2, 2017. Retrieved November 2, 2021.
  18. "2021 RNA Society Lifetime Achievement in Science Award". RNA Society. January 30, 2020. Retrieved November 2, 2021.
  19. Bluestein, Adam (August 10, 2021). "How a Moderna scientist and her team pivoted to make a COVID-19 vaccine". Fast Company . Retrieved November 2, 2021.
Melissa J. Moore
Born
SpouseJanet Kosloff
Academic background
EducationBS, Chemistry, 1984, College of William and Mary
PhD, Biological Chemistry, 1989, Massachusetts Institute of Technology
Thesis Mercuric ion reductase: mutagenesis of N- and C-terminal paired cysteines and initial crystallization studies (1989)
Doctoral advisor Christopher T. Walsh
Phillip Allen Sharp (postdoc)